Sigilon Therapeutics Inc (SGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 5,900 | 4,858 | 2,644 | 4,252 | 2,883 |
| Gross Profit | 5,900 | 4,858 | 2,644 | 4,252 | 2,883 |
| Operating Expenses | 13,335 | 12,105 | 10,374 | 12,675 | 16,919 |
| Operating Income | -7,435 | -7,247 | -7,730 | -8,423 | -14,036 |
| Interest Expense | 310 | 611 | 650 | 606 | 543 |
| Other Income | 239 | 480 | 1,695 | 358 | 233 |
| Pre-tax Income | -7,506 | -7,378 | -6,685 | -8,671 | -14,346 |
| Net Income Continuous | -7,506 | -7,378 | -6,685 | -8,671 | -14,346 |
| Net Income | $-7,506 | $-7,378 | $-6,685 | $-8,671 | $-14,346 |
| EPS Basic Total Ops | -3.00 | -2.99 | -2.56 | -3.51 | -5.76 |
| EPS Basic Continuous Ops | -3.00 | -2.96 | -2.67 | -3.48 | -5.76 |
| EPS Diluted Total Ops | -3.00 | -2.99 | -2.56 | -3.51 | -5.76 |
| EPS Diluted Continuous Ops | -3.00 | -2.96 | -2.67 | -3.48 | -5.76 |
| EPS Diluted Before Non-Recurring Items | -2.89 | -2.99 | -2.73 | -3.51 | -5.72 |
| EBITDA(a) | $-7,177 | $-6,919 | $-7,424 | $-8,135 | $-13,709 |